Condition: Major Bleeding · Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) · Sponsor: Jordan Collaborating Cardiology Group
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
This description comes directly from the study's public registry record.
Ayman Hammoudeh, MD, FACC · +96265001000 · hammoudeh_ayman@yahoo.com
Laith Habahbeh, MD · 065001000 · researchcultire2020@gmail.com
Always discuss trial participation with your own doctor first.
| Jordan University Hospital | Amman, Jordan | Recruiting |
| Istishari Hospital | Amman, Jordan | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07039149